Literature DB >> 19806241

Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: the Isfahan diabetes prevention study.

Mohsen Janghorbani1, Masoud Amini.   

Abstract

OBJECTIVES: The aim of this study was to compare the ability of fasting plasma glucose (FPG), post-load plasma glucose values and glycated hemoglobin (HbA1c) to predict progression to diabetes in non-diabetic first-degree relatives (FDR) of patients with type 2 diabetes.
METHODS: A total of 701 non-diabetic FDR of diabetic patients aged 20-70 years surveyed in 2003 to 2005 were followed until 2008 for the onset of type 2 diabetes mellitus. At baseline and at follow-ups, participants underwent a standard 75 g 2-hour oral glucose tolerance test (OGTT). Prediction of progression to type 2 diabetes was assessed by using area under the receiver-operating characteristic (ROC) curves based upon measurement of FPG, post-load glucose values and HbA1c.
RESULTS: The incidence of type 2 diabetes was 33.9 per 1000 person-years in men and 48.6 in women. The incidence rates were 4.6, 50.7, and 99.7 per 1000 person-years in FDR with normal glucose tolerance, impaired fasting glucose and impaired glucose tolerance respectively. FPG value was a better predictor of progression to diabetes than any post-load glucose values or HbA1c. The areas under the ROC curves were 0.811 for fasting, 0.752 for 1/2-hour, 0.782 for 1-hour and 0.756 for 2-hour glucose vs. 0.634 for HbA1c (p < 0.001).
CONCLUSIONS: FPG had more discriminatory power to distinguish between individuals at risk for diabetes and those who were not at risk than post-load glucose values during OGTT or HbA1c. Our findings support the American Diabetes Association recommendation of using FPG concentration to diagnose diabetes.

Entities:  

Year:  2009        PMID: 19806241      PMCID: PMC2779014          DOI: 10.1900/RDS.2009.6.117

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  28 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

Authors:  D L Rothman; I Magnusson; L D Katz; R G Shulman; G I Shulman
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

3.  Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance.

Authors:  H Larsson; G Berglund; F Lindgärde; B Ahrén
Journal:  Diabetologia       Date:  1998-09       Impact factor: 10.122

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?

Authors:  J E Shaw; P Z Zimmet; M de Courten; G K Dowse; P Chitson; H Gareeboo; F Hemraj; D Fareed; J Tuomilehto; K G Alberti
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

6.  The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association.

Authors:  E D Janus; N M Watt; K S Lam; C S Cockram; S T Siu; L J Liu; T H Lam
Journal:  Diabet Med       Date:  2000-10       Impact factor: 4.359

7.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

8.  Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis.

Authors:  O Vaccaro; G Ruffa; G Imperatore; V Iovino; A A Rivellese; G Riccardi
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

9.  Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.

Authors:  I Tsuji; K Nakamoto; T Hasegawa; A Hisashige; H Inawashiro; A Fukao; S Hisamichi
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112

10.  Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia.

Authors:  Q Qiao; J Lindström; T T Valle; J Tuomilehto
Journal:  Diabet Med       Date:  2003-12       Impact factor: 4.359

View more
  9 in total

1.  Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study.

Authors:  Mohsen Janghorbani; Masoud Amini; Ashraf Aminorroaya
Journal:  Rev Diabet Stud       Date:  2016-08-10

2.  HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.

Authors:  Manisha Nair; Dorairaj Prabhakaran; K M Venkat Narayan; Rashmi Sinha; Ramakrishnan Lakshmy; Niveditha Devasenapathy; Carrie R Daniel; Ruby Gupta; Preethi S George; Aleyamma Mathew; Nikhil Tandon; K Srinath Reddy
Journal:  Prim Care Diabetes       Date:  2011-04-06       Impact factor: 2.459

3.  Platelet mitochondrial dysfunction of DM rats and DM patients.

Authors:  Fengming Wu; Yuhan Liu; Li Luo; Yinghong Lu; David T Yew; Jie Xu; Kaihua Guo
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.

Authors:  Mohsen Janghorbani; Masoud Amini
Journal:  Rev Diabet Stud       Date:  2012-02-10

5.  The utility of diagnostic tests in the detection and prediction of glucose intolerance in the early and late postpartum period in women after gestational diabetes: a longitudinal cohort study.

Authors:  Dan Yedu Quansah; Justine Gross; Richard Mbundu-Ilunga; Jardena J Puder
Journal:  Diabetol Metab Syndr       Date:  2021-03-17       Impact factor: 3.320

6.  Weight status of the first-degree relatives of patients with type 2 diabetes based on the glucose tolerance test.

Authors:  Noureddin Soltanian; Ahmad Amini; Bijan Iraj; Gholamreza Askari; Saeed Ebneyamin; Majid Ghias; Hossein Hajian; Arash Zahed; Massoud Amini
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

7.  The association of genetic markers for type 2 diabetes with prediabetic status - cross-sectional data of a diabetes prevention trial.

Authors:  Birgit-Christiane Zyriax; Ramona Salazar; Wolfgang Hoeppner; Eik Vettorazzi; Christian Herder; Eberhard Windler
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

8.  Predictability of 1-h postload plasma glucose concentration: A 10-year retrospective cohort study.

Authors:  Lifen Kuang; Zhimin Huang; Zhenzhen Hong; Ailing Chen; Yanbing Li
Journal:  J Diabetes Investig       Date:  2015-04-27       Impact factor: 4.232

9.  Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea.

Authors:  Jin-Hee Lee; Suk Chon; Seon-Ah Cha; Sun-Young Lim; Kook-Rye Kim; Jae-Seung Yun; Sang Youl Rhee; Kun-Ho Yoon; Yu-Bae Ahn; Jeong-Taek Woo; Seung-Hyun Ko
Journal:  Korean J Intern Med       Date:  2020-03-05       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.